OMND Stock Overview
Optimind Pharma Corp. operates as a pharmaceutical company in Canada.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Optimind Pharma Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.005 |
| 52 Week High | CA$0.045 |
| 52 Week Low | CA$0.005 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | -83.33% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -96.67% |
Recent News & Updates
Recent updates
Shareholder Returns
| OMND | CA Healthcare | CA Market | |
|---|---|---|---|
| 7D | 0% | -0.9% | -0.6% |
| 1Y | -83.3% | -1.1% | 3.9% |
Return vs Industry: OMND underperformed the Canadian Healthcare industry which returned -1.1% over the past year.
Return vs Market: OMND underperformed the Canadian Market which returned 3.9% over the past year.
Price Volatility
| OMND volatility | |
|---|---|
| OMND Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 4.9% |
| Market Average Movement | 9.1% |
| 10% most volatile stocks in CA Market | 18.3% |
| 10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: OMND has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine OMND's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | David Goodman | optimindpharma.com |
Optimind Pharma Corp. operates as a pharmaceutical company in Canada. The company offers psychedelic therapies for treatment of post-traumatic stress syndrome, anxiety, depression, and other mental illnesses and disabilities by providing ketamine-assisted-treatment and other psychedelic-enhanced-psychotherapy modalities. It also operates a clinic that provides medical cannabis and other alternative treatments for various medical ailments, which include ketamine-enhanced psychotherapy.
Optimind Pharma Corp. Fundamentals Summary
| OMND fundamental statistics | |
|---|---|
| Market cap | CA$490.46k |
| Earnings (TTM) | -CA$2.68m |
| Revenue (TTM) | CA$137.97k |
3.6x
P/S Ratio-0.2x
P/E RatioIs OMND overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OMND income statement (TTM) | |
|---|---|
| Revenue | CA$137.97k |
| Cost of Revenue | CA$99.58k |
| Gross Profit | CA$38.39k |
| Other Expenses | CA$2.71m |
| Earnings | -CA$2.68m |
Last Reported Earnings
Nov 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.027 |
| Gross Margin | 27.83% |
| Net Profit Margin | -1,939.09% |
| Debt/Equity Ratio | 498.5% |
How did OMND perform over the long term?
See historical performance and comparison